Brief: Catalyst Biosciences Announces Chief Financial Officer Transition

Gyre Therapeutics

13/10/2021 23:27

Oct 13 (Reuters) - Catalyst Biosciences Inc  CBIO.O :
    * CATALYST BIOSCIENCES ANNOUNCES CHIEF FINANCIAL OFFICER
TRANSITION
    * CATALYST BIOSCIENCES INC - CFO, CLINTON MUSIL, HAS
RESIGNED FOR
PERSONAL REASONS EFFECTIVE OCTOBER 29, 2021
    * CATALYST BIOSCIENCES INC - SELINE MILLER WILL SERVE AS
INTERIM
CHIEF FINANCIAL AND PRINCIPAL ACCOUNTING OFFICER

Source text for Eikon:  ID:nGNX5gd9Dy 
Further company coverage:  CBIO.O 

 ((reuters.briefs@thomsonreuters.com;))